Eevia successfully participates at Vitafoods trade show in Geneva

Eevia Health Plc, (”Eevia” or ”The Company”), is taking part in the trade show “Vitafoods” in Geneva this week (10-12 May 2022). The Vitafoods trade show (www.vitafoods.eu.com)is one of the key trade shows for decision-makers in the global nutraceutical industry. This trade show has a great reputation over decades as a focused and high-quality B2B event, displaying the […]

Read more...

A 3,3 MSEK/0,33 MEUR sales order for bilberry extract

Eevia Health Plc, (”Eevia” or ”The Company”), has received a sales order from its Australian distributor Ingredients Plus. Ingredients Plus serves leading nutraceutical brands in Oceania and Asia with high-quality ingredients. The end customer is a major natural health company based out of Sydney, Australia selling its products across Asia and Oceania. The sales value […]

Read more...

Eevia Health appoints new distributor

Eevia Health Plc, (”Eevia” or ”The Company”) has appointed Select Ingredients, San Diego, California, USA, as new distributor in the territory of the USA. Eevia Health has appointed Select Ingredients Inc as distributor in the USA. Select Ingredients will focus on organic ingredients for food and supplements applications. The parties will also undertake a joint […]

Read more...


A new sales agreement for specialty plant-based nutraceutical extract worth SEK 8 million

Eevia Health lands a new sales agreement for specialty plant-based nutraceutical extract worth SEK 8 million Eevia Health Plc (“Eevia” or “The Company”), a leading health ingredient manufacturer from Finland, today announces that it has entered a multi-year sales agreement. The sales agreement is with a Finnish customer to supply a specialty protein and fiber […]

Read more...

Eevia Health is welcoming Harri Salo as our new Chief Manufacturing Officer

Eevia Health Plc, (”Eevia” or ”The Company”), is welcoming Harri Salo as our new Chief Manufacturing Officer. Harri Salo has a 15-year strong career in operations and production management in international industrial business environments. He will start Monday, January 10th, and significantly strengthen Eevia Health’s management capacity and competence for developing production organization, operation, and […]

Read more...


Chaga Immune study abstract

Effect of Chaga Mushroom as a Natural Immune Modulator on Upper-Respiratory Tract Infections (URTIs) and Psychological Mood State Eevia Health study conducted in collaboration with Dr. Shawn M. Talbott and GLH Nutrition, November 17, 2021 Background Heavy exercise or intense training may increase susceptibility to upper respiratory tract infections (URTI) (Nieman et al., 1990; Peters […]

Read more...

Positive results from human clinical study concluded on Feno-Chaga® Organic

Please read the full abstract of the study here. Eevia Health Plc (” Eevia” or” The Company”) has concluded a human clinical study of the effects of Eevia’s branded ingredient Feno-Chaga® Organic on Upper-Respiratory Tract Infections (URTIs) and Psychological Mood State with positive and promising results. Forty (40) healthy long-distance (marathon) runners participated in a […]

Read more...

Eevia Health Plc received new sales orders for organic pine bark extract

Eevia Health Plc, (”Eevia” or ”The Company”), announces that it has received sales orders from a leading organic supplement brand for supply of the Fenoprolic® 70 Organic (organic pine bark extract). The sales value of this start order is c.65,000 EUR, but the customer has a strong record on new product launches, and it is therefore expected to create repeat sales of this product going forward.    Eevia exhibited at the trade show “Supply Side West” in Las Vegas this week (25-28.10.21). In […]

Read more...